• Je něco špatně v tomto záznamu ?

Crosstalk between corepressor NRIP1 and cAMP signaling on adipocyte thermogenic programming

E. Tsagkaraki, A. Guilherme, SM. Nicoloro, M. Kelly, LM. Lifshitz, H. Wang, K. Min, LA. Rowland, KB. Santos, N. Wetoska, RH. Friedline, SA. Maitland, M. Chen, LS. Weinstein, SA. Wolfe, JK. Kim, MP. Czech

. 2023 ; 76 (-) : 101780. [pub] 20230722

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, U.S. Gov't, Non-P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016122

Grantová podpora
U24 DK093000 NIDDK NIH HHS - United States

OBJECTIVES: Nuclear receptor interacting protein 1 (NRIP1) suppresses energy expenditure via repression of nuclear receptors, and its depletion markedly elevates uncoupled respiration in mouse and human adipocytes. We tested whether NRIP1 deficient adipocytes implanted into obese mice would enhance whole body metabolism. Since β-adrenergic signaling through cAMP strongly promotes adipocyte thermogenesis, we tested whether the effects of NRIP1 knock-out (NRIP1KO) require the cAMP pathway. METHODS: NRIP1KO adipocytes were implanted in recipient high-fat diet (HFD) fed mice and metabolic cage studies conducted. The Nrip1 gene was disrupted by CRISPR in primary preadipocytes isolated from control vs adipose selective GsαKO (cAdGsαKO) mice prior to differentiation to adipocytes. Protein kinase A inhibitor was also used. RESULTS: Implanting NRIP1KO adipocytes into HFD fed mice enhanced whole-body glucose tolerance by increasing insulin sensitivity, reducing adiposity, and enhancing energy expenditure in the recipients. NRIP1 depletion in both control and GsαKO adipocytes was equally effective in upregulating uncoupling protein 1 (UCP1) and adipocyte beiging, while β-adrenergic signaling by CL 316,243 was abolished in GsαKO adipocytes. Combining NRIP1KO with CL 316,243 treatment synergistically increased Ucp1 gene expression and increased the adipocyte subpopulation responsive to beiging. Estrogen-related receptor α (ERRα) was dispensable for UCP1 upregulation by NRIPKO. CONCLUSIONS: The thermogenic effect of NRIP1 depletion in adipocytes causes systemic enhancement of energy expenditure when such adipocytes are implanted into obese mice. Furthermore, NRIP1KO acts independently but cooperatively with the cAMP pathway in mediating its effect on adipocyte beiging.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016122
003      
CZ-PrNML
005      
20231026110353.0
007      
ta
008      
231013s2023 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.molmet.2023.101780 $2 doi
035    __
$a (PubMed)37482187
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Tsagkaraki, Emmanouela $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Electronic address: emmanouela.tsagkaraki@umassmed.edu
245    10
$a Crosstalk between corepressor NRIP1 and cAMP signaling on adipocyte thermogenic programming / $c E. Tsagkaraki, A. Guilherme, SM. Nicoloro, M. Kelly, LM. Lifshitz, H. Wang, K. Min, LA. Rowland, KB. Santos, N. Wetoska, RH. Friedline, SA. Maitland, M. Chen, LS. Weinstein, SA. Wolfe, JK. Kim, MP. Czech
520    9_
$a OBJECTIVES: Nuclear receptor interacting protein 1 (NRIP1) suppresses energy expenditure via repression of nuclear receptors, and its depletion markedly elevates uncoupled respiration in mouse and human adipocytes. We tested whether NRIP1 deficient adipocytes implanted into obese mice would enhance whole body metabolism. Since β-adrenergic signaling through cAMP strongly promotes adipocyte thermogenesis, we tested whether the effects of NRIP1 knock-out (NRIP1KO) require the cAMP pathway. METHODS: NRIP1KO adipocytes were implanted in recipient high-fat diet (HFD) fed mice and metabolic cage studies conducted. The Nrip1 gene was disrupted by CRISPR in primary preadipocytes isolated from control vs adipose selective GsαKO (cAdGsαKO) mice prior to differentiation to adipocytes. Protein kinase A inhibitor was also used. RESULTS: Implanting NRIP1KO adipocytes into HFD fed mice enhanced whole-body glucose tolerance by increasing insulin sensitivity, reducing adiposity, and enhancing energy expenditure in the recipients. NRIP1 depletion in both control and GsαKO adipocytes was equally effective in upregulating uncoupling protein 1 (UCP1) and adipocyte beiging, while β-adrenergic signaling by CL 316,243 was abolished in GsαKO adipocytes. Combining NRIP1KO with CL 316,243 treatment synergistically increased Ucp1 gene expression and increased the adipocyte subpopulation responsive to beiging. Estrogen-related receptor α (ERRα) was dispensable for UCP1 upregulation by NRIPKO. CONCLUSIONS: The thermogenic effect of NRIP1 depletion in adipocytes causes systemic enhancement of energy expenditure when such adipocytes are implanted into obese mice. Furthermore, NRIP1KO acts independently but cooperatively with the cAMP pathway in mediating its effect on adipocyte beiging.
650    _2
$a myši $7 D051379
650    _2
$a lidé $7 D006801
650    _2
$a zvířata $7 D000818
650    _2
$a nuclear receptor interacting protein 1 $x metabolismus $7 D000078723
650    _2
$a myši obézní $7 D008820
650    12
$a tukové buňky $x metabolismus $7 D017667
650    12
$a signální transdukce $7 D015398
650    _2
$a obezita $x metabolismus $7 D009765
650    _2
$a termogeneze $x genetika $7 D022722
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
655    _2
$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
700    1_
$a Guilherme, Adilson $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Nicoloro, Sarah M $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Kelly, Mark $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Lifshitz, Lawrence M $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Wang, Hui $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Min, Kyounghee $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Rowland, Leslie A $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Santos, Kaltinaitis B $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Wetoska, Nicole $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Friedline, Randall H $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Maitland, Stacy A $u Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Chen, Min $u Metabolic Diseases Branch, NIDDK, NIH, Bethesda, MD, 20892-1752, USA
700    1_
$a Weinstein, Lee S $u Metabolic Diseases Branch, NIDDK, NIH, Bethesda, MD, 20892-1752, USA
700    1_
$a Wolfe, Scot A $u Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Kim, Jason K $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
700    1_
$a Czech, Michael P $u Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Electronic address: michael.czech@umassmed.edu
773    0_
$w MED00190571 $t Molecular metabolism $x 2212-8778 $g Roč. 76, č. - (2023), s. 101780
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37482187 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026110347 $b ABA008
999    __
$a ok $b bmc $g 1999941 $s 1202484
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 76 $c - $d 101780 $e 20230722 $i 2212-8778 $m Molecular metabolism $n Mol Metab $x MED00190571
GRA    __
$a U24 DK093000 $p NIDDK NIH HHS $2 United States
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Možnosti archivace